FDA approves expanded TREMFYA label for joint damage prevention

May 28, 2026 7:10 PM

Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration approved a supplemental Biologics License Application to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found